341 related articles for article (PubMed ID: 24549225)
41. Identification of plasma microRNAs as novel noninvasive biomarkers for early detection of lung cancer.
Tang D; Shen Y; Wang M; Yang R; Wang Z; Sui A; Jiao W; Wang Y
Eur J Cancer Prev; 2013 Nov; 22(6):540-8. PubMed ID: 23462458
[TBL] [Abstract][Full Text] [Related]
42. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.
Yuxia M; Zhennan T; Wei Z
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2045-50. PubMed ID: 22806310
[TBL] [Abstract][Full Text] [Related]
43. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
Halvorsen AR; Bjaanæs M; LeBlanc M; Holm AM; Bolstad N; Rubio L; Peñalver JC; Cervera J; Mojarrieta JC; López-Guerrero JA; Brustugun OT; Helland Å
Oncotarget; 2016 Jun; 7(24):37250-37259. PubMed ID: 27191990
[TBL] [Abstract][Full Text] [Related]
44. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
Tantai J; Hu D; Yang Y; Geng J
Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
[TBL] [Abstract][Full Text] [Related]
45. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
Wang K; Dong L; Fang Q; Xia H; Hou X
Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561
[TBL] [Abstract][Full Text] [Related]
46. Serum endothelial monocyte-activating polypeptide-II: a novel biomarker in patients with non-small-cell lung cancer.
Sen E; Ulger F; Kaya A; Akar N; Gonullu U
Clin Lung Cancer; 2008 May; 9(3):166-70. PubMed ID: 18621627
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
48. Folate Receptor-Positive Circulating Tumor Cell Detected by LT-PCR-Based Method as a Diagnostic Biomarker for Non-Small-Cell Lung Cancer.
Chen X; Zhou F; Li X; Yang G; Zhang L; Ren S; Zhao C; Deng Q; Li W; Gao G; Li A; Zhou C
J Thorac Oncol; 2015 Aug; 10(8):1163-71. PubMed ID: 26200270
[TBL] [Abstract][Full Text] [Related]
49. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
50. Blood group antigen A and flow cytometric analysis in resected early-stage non-small cell lung cancer.
Graziano SL; Tatum AH; Gonchoroff NJ; Newman NB; Kohman LJ
Clin Cancer Res; 1997 Jan; 3(1):87-93. PubMed ID: 9815542
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
Li W; Wang Y; Zhang Q; Tang L; Liu X; Dai Y; Xiao L; Huang S; Chen L; Guo Z; Lu J; Yuan K
PLoS One; 2015; 10(8):e0134220. PubMed ID: 26237047
[TBL] [Abstract][Full Text] [Related]
52. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
53. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
54. Serum tumor markers CEA, CYFRA21-1, and CA-125 are associated with worse prognosis in advanced non-small-cell lung cancer (NSCLC).
Cedrés S; Nuñez I; Longo M; Martinez P; Checa E; Torrejón D; Felip E
Clin Lung Cancer; 2011 May; 12(3):172-9. PubMed ID: 21663860
[TBL] [Abstract][Full Text] [Related]
55. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer.
Xu C; Hao K; Yu L; Zhang X
Biomarkers; 2014 Jun; 19(4):287-90. PubMed ID: 24731052
[TBL] [Abstract][Full Text] [Related]
56. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
[TBL] [Abstract][Full Text] [Related]
57. Serum tissue inhibitors of metalloproteinase-1 and -2 in patients with non-small cell lung cancer.
Suemitsu R; Yoshino I; Tomiyasu M; Fukuyama S; Okamoto T; Maehara Y
Surg Today; 2004; 34(11):896-901. PubMed ID: 15526122
[TBL] [Abstract][Full Text] [Related]
58. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
59. Prognostic potential of microRNA-138 and its target mRNA PDK1 in sera for patients with non-small cell lung cancer.
Han L; Zhang G; Zhang N; Li H; Liu Y; Fu A; Zheng Y
Med Oncol; 2014 Sep; 31(9):129. PubMed ID: 25064732
[TBL] [Abstract][Full Text] [Related]
60. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]